Contact and support
Need help, have a question, or want to contact the ResearchHub team?
© 2026 ResearchHub. Built for responsible scholarly connection.
Privacy-aware community infrastructureResearch graph
References from Comparing the risk of anaphylaxis requiring epinephrine in oral immunotherapy and subcutaneous immunotherapy: A review of recent Canadian real-world literature. Local targets link to admitted publications; unresolved targets remain external evidence.
Allergen-specific immunotherapy
10.1186/s13223-018-0282-5 · 2018 · External reference
Sublingual or subcutaneous immunotherapy for allergic rhinitis?
10.1016/j.jaci.2015.12.1298 · 2016 · External reference
Allergen immunotherapy for allergic rhinoconjunctivitis: a systemic review and meta-analysis
10.1111/all.13201 · 2017 · External reference
Allergen immunotherapy: an updated review of safety
10.1097/aci.0000000000000335 · 2017 · External reference
A single centre retrospective study of systemic reactions to subcutaneous immunotherapy
10.1186/s13223-020-00491-5 · 2020 · External reference
Systemic reactions to subcutaneous allergen immunotherapy: real-world cause and effect modelling
10.1186/s13223-021-00566-x · 2021 · External reference
Oral immunotherapy for peanut allergy (PACE): a systematic review and meta-analysis of efficacy and safety
10.1016/s0140-6736(19)30420-9 · 2019 · External reference
Current management and use of oral immunotherapy in the United States for patients with peanut allergy
10.2500/aap.2019.40.4228 · 2019 · External reference
Allergist-reported trends in the practice of food allergen oral immunotherapy
10.1016/j.jaip.2014.06.023 · 2015 · External reference
A high proportion of Canadian allergists offer oral immunotherapy but barriers remain
10.1016/j.jaip.2020.12.025 · 2021 · External reference
CSACI guidelines for the ethical, evidence-based and patient-oriented clinical practice of oral immunotherapy in IgE-mediated food allergy
2020 · External reference
First real-world safety analysis of preschool peanut oral immunotherapy
10.1016/j.jaip.2019.04.010 · 2019 · External reference
Impact of age on adherence and efficacy of peanut oral-immunotherapy using a standardized protocol
10.1111/pai.13447 · 2021 · External reference
Real-world experience with peanut oral immunotherapy: lessons learned from 270 patients
10.1016/j.jaip.2018.05.023 · 2019 · External reference
Oral and sublingual immunotherapy for egg allergy
2018 · External reference
Systemic reactions to subcutaneous immunotherapy: effects of dosing and aeroallergen content
10.1016/j.anai.2019.06.021 · 2019 · External reference
AAAI/ACAAI subcutaneous immunotherapy surveillance study (2013-2017): fatalities, infections, delayed reactions, and use of epinephrine autoinjectors
10.1016/j.jaip.2019.01.058 · 2019 · External reference
Three-year follow up after peanut food challenges: accidental reactions in allergic children and introduction failure in tolerant children
10.1016/j.jaci.2019.09.011 · 2019 · External reference
Community use of epinephrine for the treatment of anaphylaxis: a review and meta-analysis
10.1016/j.jaip.2021.01.038 · 2021 · External reference
Food allergy
10.1016/j.jaci.2009.08.028 · 2010 · External reference
Parents’ and caregivers’ experiences and behaviours when eating out with children with a food hypersensitivity
10.1186/s12889-017-4594-z · 2018 · External reference
A qualitative investigation into the maternal experience of having a young child with severe food allergy
10.1177/1359104511415636 · 2012 · External reference
A qualitative study of families of a child with a nut allergy
10.1177/1742395311411591 · 2011 · External reference
GRADE-ing the benefit/risk equation in food immunotherapy
10.1007/s11882-019-0862-6 · 2019 · External reference
The value of oral immunotherapy
10.1111/all.14072 · 2019 · External reference
The psychosocial impact of food allergy and food hypersensitivity in children, adolescents and their families: a review
10.1111/j.1398-9995.2010.02342.x · 2010 · External reference
